Table 2. The relative performance of serological tests against statutory post-mortem diagnostic techniques.
Test type | n | Comparator | P-value | AUC | Sens | Spec | PPV | NPV | Prev. (comparator) | Test prev. |
---|---|---|---|---|---|---|---|---|---|---|
ENFER 2ag | 283 | Visible lesion | 0.002 | 0.55 | 12.80% | 97.60% | 66.70% | 74.60% | 28% | 5.30% |
ENFER 2ag | 285 | Confirmed | 0.003 | 0.55 | 12.70% | 97.20% | 60.00% | 77.00% | 25% | 5.26% |
ENFER 4ag | 283 | Visible lesion | 0.007 | 0.54 | 8.97% | 98.50% | 70.00% | 68.40% | 28% | 3.53% |
ENFER 4ag | 285 | Confirmed | 0.004 | 0.54 | 9.86% | 98.60% | 70.00% | 76.50% | 25% | 3.51% |
IDEXX | 284 | Visible lesion | 0.001 | 0.56 | 14.10% | 97.10% | 64.70% | 74.90% | 27% | 5.99% |
IDEXX | 286 | Confirmed | 0.002 | 0.55 | 14.10% | 96.70% | 58.80% | 77.30% | 25% | 5.94% |